ConsortiEX Verify on Receipt: Automated DSCSA Compliance at the Point of Receiving

ConsortiEX launched Verify on Receipt, a barcode scanning system that automates DSCSA product verification during pharmacy and distributor receiving workflows. The technology addresses the saleable returns requirement under 21 U.S.C. § 360eee-1(b)(4)(B), which mandates verification of product identifier, lot number, expiration date, and transaction history before accepting returns into saleable inventory.

DSCSA Saleable Returns Requirement

The Drug Supply Chain Security Act requires dispensers and distributors to verify four data elements before accepting product returns as saleable stock:

1. Product identifier (NDC + serial number)
2. Lot number
3. Expiration date
4. Transaction history (proof of prior ownership and chain of custody)

Under 21 CFR 1271.430(d), verification must occur at the point a product is determined to be saleable. This typically happens during receiving, when returns are inspected and either accepted into inventory or quarantined for destruction. Manual verification—cross-referencing barcode scans against transaction statements and pedigree documents—creates operational bottlenecks. A mid-size specialty pharmacy processing 200 returns monthly spends approximately 15-20 minutes per product verifying DSCSA compliance manually.

FDA's November 27, 2023 DSCSA Enhanced Drug Distribution Security final rule established enforcement priorities for verification requirements. While the FDA has exercised enforcement discretion on certain interoperability delays (EPCIS 1.2 adoption timelines), verification of saleable returns remains an active enforcement focus. Warning letters issued in 2024 to three wholesale drug distributors cited failures to verify transaction history before accepting returns.

How Verify on Receipt Works

ConsortiEX Verify on Receipt integrates with existing warehouse management systems and barcode scanners. The receiving workflow operates as follows:

1. Pharmacy or distributor scans the 2D Data Matrix barcode on the incoming return
2. The system extracts the serialized National Drug Code (sNDC), lot number, and expiration date
3. Verify on Receipt queries the entity's transaction database (typically stored in an ATP-compliant repository) to confirm the product's chain of custody
4. If all four DSCSA elements match and the product's pedigree is intact, the system flags the item as saleable
5. If verification fails (missing transaction data, mismatched lot number, or expired product), the item is quarantined and flagged for investigation

The technology does not replace transaction data storage requirements. Entities must still maintain ATP-compliant transaction information systems—Verify on Receipt automates the cross-referencing step.

Operational Impact on Distributors and Pharmacies

Wholesale drug distributors accepting returns from downstream trading partners face the highest verification burden. A regional distributor processing returns from 50 pharmacy customers must verify each product's transaction history to confirm it was sold through an authorized channel. Without automation, this requires warehouse staff to manually pull transaction statements, compare serial numbers, and document the verification.

Specialty pharmacies managing high-cost biologics have additional compliance pressure. A single return of a $15,000 oncology product requires the same verification rigor as a $20 generic—but the financial and regulatory risk of an unverified saleable return is substantially higher. Verify on Receipt reduces verification time from 15-20 minutes per product to under 60 seconds, according to ConsortiEX pilot data from three specialty pharmacy beta testers.

Third-party logistics providers operating under warehouse services agreements inherit their client's DSCSA obligations. If a 3PL accepts returns on behalf of a distributor client, the 3PL must perform verification or provide documented evidence that the client completed verification before the product entered the 3PL's inventory. Automated verification systems clarify this handoff by generating timestamped verification records that satisfy both parties' documentation requirements.

What ColdChainCheck Data Shows

Of the 1,275 wholesale drug distributors and 3PLs tracked in ColdChainCheck's directory, 1,234 hold active FDA registration—a baseline requirement for handling prescription drug returns. However, FDA registration does not indicate whether an entity has implemented automated verification technology. The 51/100 average compliance score across the directory reflects verified licensure, accreditation, and enforcement history—not operational readiness for DSCSA saleable returns workflows.

The compliance score distribution reveals verification automation is likely concentrated among high-scoring entities. The 28 entities in the "Excellent" tier (80-100 score) typically include large national distributors (McKesson, AmerisourceBergen, Cardinal Health) and NABP-accredited 3PLs with documented quality management systems. These entities invest in EPCIS-compliant ATP systems and serialization infrastructure. The 919 entities in the "Fair" tier (40-59 score)—72% of the directory—represent mid-size regional distributors and specialty pharmacy wholesalers. This segment is most likely to rely on manual verification or hybrid workflows where barcode scanning exists but transaction history cross-referencing remains manual.

Automated verification systems like ConsortiEX Verify on Receipt do not directly affect an entity's compliance score—ColdChainCheck does not track technology vendor selection. However, entities with enforcement actions on record may face heightened scrutiny during FDA inspections. Of the 73 entities with FDA recalls or warning letters in ColdChainCheck's database, 18 citations involve transaction documentation failures (missing pedigrees, incomplete transaction statements, or inability to produce verification records during inspection). Automation reduces this risk by generating auditable verification logs.

Practical Guidance for QA and Procurement Teams

• Audit your returns verification workflow. If your team spends more than 5 minutes per product verifying saleable returns, quantify the labor cost and compare it to automation ROI. A distributor processing 500 returns monthly at 15 minutes per verification spends 125 hours/month on manual compliance.
• Check trading partner compliance posture. Use the ColdChainCheck directory to verify that upstream suppliers and downstream customers hold active FDA registration and state licenses. If a trading partner lacks verified transaction data, your verification workflow will fail regardless of automation.
• Document verification failures. When Verify on Receipt (or any verification system) flags a product as non-saleable, quarantine the item and document the reason. This creates an audit trail if FDA questions why certain returns were rejected.
• Review NABP accreditation status. Only 63 entities in the directory hold NABP accreditation (formerly VAWD). Accredited entities undergo annual audits of their transaction documentation processes. If you accept returns from non-accredited sources, automated verification becomes critical to compensate for lack of third-party QMS validation.

For detailed requirements on DSCSA saleable returns workflows, see the DSCSA Compliance Checklist for Wholesale Distributors. ColdChainCheck tracks FDA enforcement actions, state board of pharmacy disciplinary records, and NABP accreditation status.

Disclaimer: This article provides informational content based on publicly available regulatory sources and ColdChainCheck directory data. It is not legal or compliance advice. Verify all DSCSA verification requirements with legal counsel and the relevant regulatory authority.